Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2005

View Archived Issues

Fumaric acid esters show promise in the treatment of multiple sclerosis

Greater efficacy found with a duloxetine/PFMT combination in women with SUI

VEGFR-2/EGFR inhibitor displays efficacy in a mouse model of intestinal cancer

Oxoglaucine exhibits promising antienteroviral spectrum

New data on the therapeutic benefits of ropinirole in RLS

AT1-Mas receptor complex: a novel target for cardiovascular disease involving enhanced Ang II action

Intravesical hyaluronic acid proven effective in the management of urinary tract infections

CHIR-12.12 enters phase I

Equetro available for manic and mixed episodes in bipolar I disorder

Phase II/III MEND-CABG trial recommended to continue

New phase II safety study for BLP25 Liposome Vaccine

SkyePharma and Mundipharma enter DepoBupivacaine agreement

Cypher stent approved for MRI scans immediately following implantation

Jazz Pharmaceuticals to acquire Orphan Medical

NDA planned for orBec in iGVHD

Enrollment completed in study of darusentan for resistant systolic hypertension

Insmed studies SomatoKine for HIV-associated lipodystrophy

Genmab reaches SPA agreement for HuMax-CD4 pivotal study

Specific IGF-IR kinase inhibitor inhibits angiogenesis, enhances sensitivity to chemotherapy

Novel small molecule prevents chemotherapy/radiation-induced side effects

PTC Therapeutics identifies compound inhibiting VEGF expression via a novel mechanism

Array BioPharma presents orally active small-molecule inhibitors of EGFR and/or ErbB-2

Fast track designation for terlipressin in type 1 hepatorenal syndrome

European approval for Aclasta in Paget's disease of the bone

Recent patents describe new treatments for inflammatory and autoimmune diseases

New therapeutic agents for gastrointestinal disorders claimed

Theravance presents novel agents for overactive bladder

New therapeutic agents for cardiovascular diseases reported in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...